|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nagase S, Ohta T, Takahashi F, Yamagami W
and Yaegashi N: Board Members of the 2020 Committee on Gynecologic
Oncology of the Japan Society of Obstetrics and Gynecology. Annual
report of the Committee on Gynecologic Oncology, the Japan Society
of Obstetrics and Gynecology: Annual patient report for 2018 and
annual treatment report for 2013. J Obstet Gynaecol Res.
48:541–552. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shigeta S, Shida M, Nagase S, Ikeda M,
Takahashi F, Shibata T, Yamagami W, Katabuchi H, Yaegashi N, Aoki D
and Mikami M: Epidemiological guideline influence on the
therapeutic trend and patient outcome of uterine cervical cancer in
Japan: Japan society of gynecologic oncology guideline evaluation
committee project. Gynecol Oncol. 159:248–255. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sedlis A, Bundy BN, Rotman MZ, Lentz SS,
Muderspach LI and Zaino RJ: A randomized trial of pelvic radiation
therapy versus no further therapy in selected patients with stage
IB carcinoma of the cervix after radical hysterectomy and pelvic
lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol.
73:177–183. 1999.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ryu SY, Kim MH, Nam BH, Lee TS, Song ES,
Park CY, Kim JW, Kim YB, Ryu HS, Park SY, et al: Intermediate-risk
grouping of cervical cancer patients treated with radical
hysterectomy: A Korean Gynecologic Oncology Group study. Br J
Cancer. 110:278–285. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Noh JM, Park W, Kim YS, Kim JY, Kim HJ,
Kim J, Kim JH, Yoon MS, Choi JH, Yoon WS, et al: Comparison of
clinical outcomes of adenocarcinoma and adenosquamous carcinoma in
uterine cervical cancer patients receiving surgical resection
followed by radiotherapy: A multicenter retrospective study (KROG
13-10). Gynecol Oncol. 132:618–623. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Diaz ES, Aoyama C, Baquing MA, Beavis A,
Silva E, Holschneider C and Cass I: Predictors of residual
carcinoma or carcinoma-in-situ at hysterectomy following cervical
conization with positive margins. Gynecol Oncol. 132:76–80.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Estape RE, Angioli R, Madrigal M, Janicek
M, Gomez C, Penalver M and Averette H: Close vaginal margins as a
prognostic factor after radical hysterectomy. Gynecol Oncol.
68:229–232. 1998.PubMed/NCBI View Article : Google Scholar
|
|
9
|
NCCN Clinical Practice Guidelines in
Oncology (NCCN Guidelines): Cervical Cancer. Version 1. National
Comprehensive Cancer Network, 2023.
|
|
10
|
Tanio A, Saito H, Amisaki M, Hara K,
Sugezawa K, Uejima C, Tada Y, Kihara K, Yamamoto M, Nosaka K, et
al: AMIGO2 as a novel indicator of liver metastasis in patients
with colorectal cancer. Oncol Lett. 21(278)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Goto K, Morimoto M, Osaki M, Tanio A,
Izutsu R, Fujiwara Y and Okada F: The impact of AMIGO2 on prognosis
and hepatic metastasis in gastric cancer patients. BMC Cancer.
22(280)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Olawaiye AB, Baker TP, Washington MK and
Mutch DG: The new (Version 9) American Joint Committee on Cancer
tumor, node, metastasis staging for cervical cancer. CA Cancer J
Clin. 71:287–298. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Goto K, Osaki M, Izutsu R, Tanaka H,
Sasaki R, Tanio A, Satofuka H, Kazuki Y, Yamamoto M, Kugoh H, et
al: Establishment of an antibody specific for AMIGO2 improves
immunohistochemical evaluation of liver metastases and clinical
outcomes in patients with colorectal cancer. Diagn Pathol.
17(16)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kanda Y, Osaki M, Onuma K, Sonoda A,
Kobayashi M, Hamada J, Nicolson GL, Ochiya T and Okada F:
Amigo2-upregulation in tumour cells facilitates their attachment to
liver endothelial cells resulting in liver metastases. Sci Rep.
7(43567)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Izutsu R, Osaki M, Jehung JP, Seong HK and
Okada F: Liver Metastasis formation is defined by AMIGO2 expression
via adhesion to hepatic endothelial cells in human gastric and
colorectal cancer cells. Pathol Res Pract.
237(154015)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu Y, Yang J, Shi Z, Tan X, Jin N,
O'Brien C, Ott C, Grisoli A, Lee E, Volk K, et al: In vivo
selection of highly metastatic human ovarian cancer sublines
reveals role for AMIGO2 in intra-peritoneal metastatic regulation.
Cancer Lett. 503:163–173. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Landoni F, Maneo A, Colombo A, Placa F,
Milani R, Perego P, Favini G, Ferri L and Mangioni C: Randamised
study of radical surgery versus radiotherapy for stage Ib-IIa
cervical cancer. Lancet. 350:535–540. 1997.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shigeta S, Shimada M, Tsuji K, Nagai T,
Tanase Y, Matsuo K, Kamiura S, Iwata T, Yokota H and Mikami M: Risk
assessment in the patients with uterine cervical cancer harboring
intermediate risk factors after radical hysterectomy: A
multicenter, retrospective analysis by the Japanese Gynecologic
Oncology Group. Int J Clin Oncol. 27:1507–1515. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shimada M, Kigawa J, Takahashi M, Minagawa
Y, Okada M, Kanamori Y, Itamochi H, Oishi T, Iba T and Terakawa N:
Stromal invasion of the cervix can be excluded from the criteria
for using adjuvant radiotherapy following radical surgery for
patients with cervical cancer. Gynecol Oncol. 93:628–631.
2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Osaku D, Komatsu H, Okawa M, Iida Y, Sato
S, Oishi T and Harada T: Re-classification of uterine cervical
cancer cases treated with radical hysterectomy based on the 2018
FIGO staging system. Taiwan J Obstet Gynecol. 60:1054–1058.
2021.PubMed/NCBI View Article : Google Scholar
|
